Delivery Order SPE2DB24D3013-SPE2DB25FFKEG

Award Date 3/14/25
Potential Completion Date 3/17/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,402,493 units of the drug dextroamphetamine-amphetamine 20 mg capsules in 100 count bottles. The contract has a ceiling value of $4,703.17 and runs through April 26, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,550 units of Dextroamphetamine-amphetamine 30 mg capsules. The contract has a ceiling value of $2,099.13 and an ultimate completion date of August 23, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded this contract to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of 4,563,790,421 units of Dextroamphetamine-Amphetamine 10 mg capsules in quantities of 100 per bottle. The contract has a completion date of February 28, 2024 and a potential value of $1,320.00....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is valued at $2,780.68 and has an ultimate completion date of March 29, 2024. The contract requires the delivery of 4564110990 - Dextroamphetamine-Amphetamine 20 mg capsules, 100-count, to support military treatment programs and facilities. This delivery order is...
The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,816,763 units of Dextroamphetamine-Amphetamine 30 mg capsules. This $3,677.76 contract has a performance period through March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,585,317 units of dextroamphetamine-amphetamine 20 mg capsules in 100-count bottles, with a total ceiling value of $1,475.55. The contract has an ultimate completion date of March 17, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,738.81 firm-fixed-price contract is for the supply of 4557932058 Dextroamphetamine-Amphetamine ER 20 mg capsules. The contract has an ultimate completion date of July 29, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a leading pharmaceutical distribution company, for the supply of 4,564,588,399 units of the prescription drug Dextroamphetamine-Amphetamine 30mg capsules. The contract has a ceiling value of $1,124.16 and is a firm fixed-price delivery order with a completion date of May 14, 2024. Amerisourcebergen Drug Corporation is a subsidiary of Cencora, Inc. and has extensive experience...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $2,107.80 firm fixed price contract is for the supply of 4,564,205,040 30mg capsules of the amphetamine medication Dextroamphetamine-Amphetamine. The contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor and the contract does not have a set-aside designation. This delivery...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $1,761.89 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,560,135,898 units of the medication dextroamphetamine-amphetamine 20 mg capsules. The contract has an ultimate completion date of March 2, 2023 and was awarded on March 1, 2023. This contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFKEG
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,243.78, is for the delivery of 4,567,584,945 units of the drug Dextroamphetamine-Amphetamine 20 mg capsules in 100-count bottles. The contract has a period of performance through March 17, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and does not have any set-aside designations. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/13/25, 10:05 AM